CHRISTUS MOTHER FRANCES HOSP-TYLER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $787K
- Transactions
- 270
- Companies
- 40
- Average per transaction
- $2,914
Who reported the payments
| Angiodynamics, Inc. | $280,450 |
| Impulse Dynamics (USA) Inc. | $59,977 |
| Stryker | $53,574 |
| Olympus Corporation | $44,019 |
| Abbott | $35,220 |
| Boston Scientific | $32,500 |
| Pfizer | $25,500 |
| Novartis | $19,000 |
| AstraZeneca | $17,000 |
| Diagnostica Stago, Inc | $13,750 |
| Carter Bloodcare | $12,530 |
| Hill-rom Company, Inc | $12,050 |
| Boehringer Ingelheim | $11,000 |
| Siemens Medical Solutions USA, Inc. | $8,042 |
| Merck | $8,000 |
| Astellas Pharma US Inc | $7,500 |
| Haemonetics Corporation | $7,500 |
| Ipsen Biopharmaceuticals, Inc | $7,500 |
| Genentech USA, Inc. | $6,500 |
| KCI USA, Inc. | $6,000 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $5,500 |
| Roche Diagnostics Corporation | $5,500 |
| Aesculap, Inc. | $5,027 |
| Johnson & Johnson | $5,000 |
| Penumbra, Inc. | $5,000 |
| Eisai Inc. | $5,000 |
| Medical Device Business Services, Inc. | $5,000 |
| CSL Behring | $5,000 |
| Edwards Lifesciences | $4,756 |
| Chiesi USA, Inc. | $4,500 |
| Alnylam Pharmaceuticals Inc. | $4,000 |
| Bayer | $4,000 |
| Novo Nordisk | $3,000 |
| Insulet Corporation | $3,000 |
| Kyowa Kirin, Inc. | $3,000 |
| Baxter Healthcare | $2,837 |
| UCB, Inc. | $2,500 |
| Fresenius Kabi USA, LLC | $2,500 |
| Shionogi Inc | $2,500 |
| Taiho Oncology, Inc. | $2,500 |